Broadening Coverage

Should be considered in patients with life-threatening infections (ventilator-associated pneumonia, sepsis).

Second agent should offer additional coverage and generally should be an aminoglycoside at UCLA.

Coverage MUST be narrowed based on culture results; negative cultures can be used to rule out infections with most organisms